Column Group IV GP, LP bought $1M of EIKN stock

Column Group IV GP, LP, 10% owner of Eikon Therapeutics, Inc. (EIKN), bought 89,200 shares of EIKN stock worth $1M, per an SEC Form 4 filed Sep 8, 2026.

It was an open-market purchase.

The trade happened on Sep 3, 2026, 5 days before it was made public.

EIKN has moved -44.9% since the trade date, from $10.96 to $6.04 (Nov 12, 2026 close).